Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
The purpose of this study was to develop techniques for identifying cancer biomarkers in human serum using differential in-gel electrophoresis (DIGE), and characterizing the protein biomarkers using tandem mass spectrometry (MS/MS). A major problem in profiling protein expression by DIGE comes from the presence of high concentrations of a small number of proteins. Therefore, serum samples were first chromatographed using an immunoaffinity HPLC column (Agilent Technologies), to selectively remove albumin, immunoglobulins, transferrin, haptoglobin, and antitrypsin. Serum samples from three individuals with pancreatic cancer and three individuals without cancer were compared. Serum samples were processed using the immunoaffinity column. Differential protein analysis was performed using DIGE. A total of 56 protein spot-features were found to be significantly increased and 43 significantly decreased in cancer serum samples. These spot features were excised, trypsin digested, and analyzed by MALDI/TOF/TOF (4700 Proteomics Analyzer, Applied Biosystems). We identified 24 unique proteins that were increased and 17 unique proteins that were decreased in cancer serum samples. Western blot analysis confirmed increased levels of several of these proteins in the pancreatic cancer serum samples. In an independent series of serum samples from 20 patients with pancreatic cancer and 14 controls, increased levels of apolipoprotein E, alpha-1-antichymotrypsin, and inter-alpha-trypsin inhibitor were found to be associated with pancreatic cancer. These results suggest that affinity column enrichment and 2-D DIGE can be used to identify numerous proteins differentially expressed in serum from individuals with pancreatic cancer.
Yu
Kenneth H
KH
Division of Hematology/Oncology, Center for Cancer Pharmacology, and Genomics Institute, University of Pennsylvania, 421 Curie Boulevard, Philadelphia, PA 19104-6160, USA.
Rustgi
Anil K
AK
Blair
Ian A
IA
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000418:Albumins / Q000737:chemistry; D001057:Apolipoproteins E / Q000737:chemistry; D015415:Biomarkers / Q000737:chemistry; D001798:Blood Proteins / Q000737:chemistry*; D015153:Blotting, Western; D018395:CA-19-9 Antigen / Q000737:chemistry; D045744:Cell Line, Tumor; D002846:Chromatography, Affinity; D002851:Chromatography, High Pressure Liquid; D015180:Electrophoresis, Gel, Two-Dimensional / Q000379:methods*; D005260:Female; D006242:Haptoglobins / Q000737:chemistry; D006801:Humans; D007091:Image Processing, Computer-Assisted; D007136:Immunoglobulins / Q000737:chemistry; D008297:Male; D013058:Mass Spectrometry; D008875:Middle Aged; D015233:Models, Statistical; D015999:Multivariate Analysis; D010190:Pancreatic Neoplasms / Q000097:blood* / Q000378:metabolism; D011237:Predictive Value of Tests; D015995:Prevalence; D011506:Proteins / Q000737:chemistry*; D020543:Proteome; D040901:Proteomics / Q000379:methods*; D012044:Regression Analysis; D012680:Sensitivity and Specificity; D012737:Sex Factors; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization / Q000379:methods*; D014168:Transferrin / Q000737:chemistry; D014357:Trypsin / Q000494:pharmacology; D000515:alpha 1-Antitrypsin / Q000737:chemistry / Q000494:pharmacology
D000418:Albumins; D001057:Apolipoproteins E; D015415:Biomarkers; D001798:Blood Proteins; D018395:CA-19-9 Antigen; D006242:Haptoglobins; D007136:Immunoglobulins; D011506:Proteins; D020543:Proteome; D014168:Transferrin; D000515:alpha 1-Antitrypsin; D014357:Trypsin